Shuliang Zhou

684 total citations
13 papers, 410 citations indexed

About

Shuliang Zhou is a scholar working on Infectious Diseases, Molecular Biology and Neurology. According to data from OpenAlex, Shuliang Zhou has authored 13 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Shuliang Zhou's work include COVID-19 Clinical Research Studies (4 papers), Long-Term Effects of COVID-19 (4 papers) and Sepsis Diagnosis and Treatment (3 papers). Shuliang Zhou is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), Long-Term Effects of COVID-19 (4 papers) and Sepsis Diagnosis and Treatment (3 papers). Shuliang Zhou collaborates with scholars based in China, Estonia and United Kingdom. Shuliang Zhou's co-authors include Dawei Wang, Zhiyong Peng, Xingguo Zhang, Chang Hu, Bo Hu, John R. Prowle, Yirong Li, Yimei Yin, Xing Liu and Haibo Xu and has published in prestigious journals such as Scientific Reports, Critical Care and Oncotarget.

In The Last Decade

Shuliang Zhou

13 papers receiving 398 citations

Peers

Shuliang Zhou
Comparison fields: 5 of 76
  • Infectious Diseases 229
  • Neurology 133
  • Oncology 101
  • Molecular Biology 75
  • Pulmonary and Respiratory Medicine 70
Replace Hangxiang Du with:
Hangxiang Du China
Xiaobei Chen China
Ding Long China
Navid Ahmadi Poland
Huihui Yue China
Kai Dai China
Manli Miao China
Xiuqi Wei China
Hangxiang Du China View profile →
Citations per field, relative to Shuliang Zhou
Shuliang Zhou · 1×
Citations per year, relative to Shuliang Zhou
Shuliang Zhou · 1×

Countries citing papers authored by Shuliang Zhou

Since Specialization
Citations

This map shows the geographic impact of Shuliang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuliang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuliang Zhou more than expected).

Fields of papers citing papers by Shuliang Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuliang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuliang Zhou. The network helps show where Shuliang Zhou may publish in the future.

Co-authorship network of co-authors of Shuliang Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Shuliang Zhou. A scholar is included among the top collaborators of Shuliang Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuliang Zhou. Shuliang Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
# Work Indexed citations
1 1
2 10
3 252
4 13
5 5
6 22
7 5
8 10
9 46
10 28
11 16
12
[Experimental studies on antitumor activity of new recombinant human tumour necrosis factor in nude mice bearing nasopharyngeal carcinoma].
1
13 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026